C121H134F15N29O10S5 — CID 159284788
5-[6-[4-[1-(cyclohexylmethyl)azetidin-3-yl]phenyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]-7-azaspiro[3.5]nonane;4-[2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]ethyl]piperidine;1-[[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]methyl]cyclopropan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]piperidine (PubChem CID 159284788) has the molecular formula C121H134F15N29O10S5 and a molecular weight of 2599.90 g/mol. Its IUPAC name is 5-[6-[4-[1-(cyclohexylmethyl)azetidin-3-yl]phenyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]-7-azaspiro[3.5]nonane;4-[2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]ethyl]piperidine;1-[[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]methyl]cyclopropan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]piperidine.
| Compound Name | 5-[6-[4-[1-(cyclohexylmethyl)azetidin-3-yl]phenyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]-7-azaspiro[3.5]nonane;4-[2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]ethyl]piperidine;1-[[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]methyl]cyclopropan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]piperidine |
|---|---|
| PubChem CID | 159284788 |
| Molecular Formula | C121H134F15N29O10S5 |
| Molecular Weight | 2599.90 g/mol |
| Exact Mass | 2597.92 |
| IUPAC Name | 5-[6-[4-[1-(cyclohexylmethyl)azetidin-3-yl]phenyl]-2-methylsulfonyl-3-(trifluoromethyl)phenyl]-2H-tetrazole;2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]-7-azaspiro[3.5]nonane;4-[2-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]ethyl]piperidine;1-[[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]methyl]cyclopropan-1-amine;4-[3-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]azetidin-1-yl]piperidine |
| SMILES | CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(C4CC5(CCNCC5)C4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(C4CCNCC4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(CC4(N)CC4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(CC4CCCCC4)C3)cc2)c1-c1nn[nH]n1.CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CN(CCC4CCNCC4)C3)cc2)c1-c1nn[nH]n1 |
| InChI | InChI=1S/C26H29F3N6O2S.C25H29F3N6O2S.C25H28F3N5O2S.C23H25F3N6O2S.C22H23F3N6O2S/c1-38(36,37)23-21(26(27,28)29)7-6-20(22(23)24-31-33-34-32-24)17-4-2-16(3-5-17)18-14-35(15-18)19-12-25(13-19)8-10-30-11-9-25;1-37(35,36)23-21(25(26,27)28)7-6-20(22(23)24-30-32-33-31-24)18-4-2-17(3-5-18)19-14-34(15-19)13-10-16-8-11-29-12-9-16;1-36(34,35)23-21(25(26,27)28)12-11-20(22(23)24-29-31-32-30-24)18-9-7-17(8-10-18)19-14-33(15-19)13-16-5-3-2-4-6-16;1-35(33,34)21-19(23(24,25)26)7-6-18(20(21)22-28-30-31-29-22)15-4-2-14(3-5-15)16-12-32(13-16)17-8-10-27-11-9-17;1-34(32,33)19-17(22(23,24)25)7-6-16(18(19)20-27-29-30-28-20)14-4-2-13(3-5-14)15-10-31(11-15)12-21(26)8-9-21/h2-7,18-19,30H,8-15H2,1H3,(H,31,32,33,34);2-7,16,19,29H,8-15H2,1H3,(H,30,31,32,33);7-12,16,19H,2-6,13-15H2,1H3,(H,29,30,31,32);2-7,16-17,27H,8-13H2,1H3,(H,28,29,30,31);2-7,15H,8-12,26H2,1H3,(H,27,28,29,30) |
| InChIKey | KZJJURSJODADKO-UHFFFAOYSA-N |
| XLogP | 18.52 |
| TPSA | 521.31 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 34 |
| Rotatable Bonds | 29 |
| Heavy Atoms | 180 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2599.90 |
| LogP ≤ 5 | 18.52 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 34 |